Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study is to investigate the clinical efficacy and safety of Nucleoside (acid) analogues
treatment in patients with normal Alanine Aminotransferase and positive Hepatitis B virus
DNA.